Cambridge, MA
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle cell anemia. This understanding drives their integration of artificial intelligence (AI), computation, and biological automation to accelerate the design of small molecule and protein therapeutics.
1910genetics.comThese are collections 1910 Genetics is a part of. Click on the collection name to view similar companies.
Grant
$550,000
Series A
$22,000,000
Seed
$4,100,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on 1910 Genetics.